Mohammad Hirmand, M.D.
Board Member
Whitehawk Therapeutics, Inc. (WHWK)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mohammad Hirmand, M.D.
Mohammad Hirmand, M.D. is recorded as Board Member at Whitehawk Therapeutics, Inc. (WHWK). Whitehawk Therapeutics, Inc. reported in an 8-K filed March 28, 2023 that Mohammad Hirmand, M.D. was appointed Class II director, effective March 27, 2023.
“On March 24, 2023, Mohammad Hirmand, M.D. was appointed a Class II director by the Board of Directors (the “Board”) of the Company, effective March 27, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-03-27–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Whitehawk Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brendan Delaney CEO, COO, Board Member
- David J. Lennon CEO, Board Member
- David Lennon CEO, Board Member
- Neil Desai, Ph.D. CEO, Board Member
- Stephen Hoffman CEO
- Caley Castelein, M.D. Chairman
- Neil Desai Chairman, Board Member
- Lance Thibault CFO
- Scott Giacobello CFO, Chief Accounting Officer
- Anupam Dalal Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.